OMNICELL, INC.
No enriched coverage for $OMCL in the last 7 days.
No SEC Form 4 filings for $OMCL in the last 30 days.
Vanguard Capital Management has disclosed beneficial ownership of 2,274,766 shares of Omnicell (NASDAQ: OMCL) common stock, representing a 5% stake. This filing, a Schedule 13G, indicates a passive investment rather than an intent to influence the company. Vanguard holds sole dispositive power over all these shares and sole voting power over 340,249 shares.
Omnicell Inc (OMCL) shares fell 3.0% to $34.40. The company is considered undervalued by 9.3% based on its GF Value™ of $37.91, yet its GF Score™ of 79/100 suggests above-average quality. Despite the undervaluation, its current P/E ratio of 860.0x is significantly higher than its 5-year median, and insiders have sold $0.4 million worth of shares recently, with no reported buying, indicating a cautious outlook.
Omnicell, Inc. CEO Randall A. Lipps reported the vesting of 79,494 performance-based restricted stock units (RSUs) after the company met specific stock performance objectives. In connection with this vesting, 15,642 shares were withheld for tax liabilities at $34.40 per share. Following these transactions, Lipps directly holds 444,592 Common Stock shares, with additional shares held indirectly in trusts.
